These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12539865)

  • 41. Species extrapolation of life-stage physiologically-based pharmacokinetic (PBPK) models to investigate the developmental toxicology of ethanol using in vitro to in vivo (IVIVE) methods.
    Martin SA; McLanahan ED; Bushnell PJ; Hunter ES; El-Masri H
    Toxicol Sci; 2015 Feb; 143(2):512-35. PubMed ID: 25410581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Perchlorate regulation faces further delay.
    Renner R
    Environ Sci Technol; 2003 May; 37(9):166A-167A. PubMed ID: 12775032
    [No Abstract]   [Full Text] [Related]  

  • 43. Derivation of a bisphenol A oral reference dose (RfD) and drinking-water equivalent concentration.
    Willhite CC; Ball GL; McLellan CJ
    J Toxicol Environ Health B Crit Rev; 2008 Feb; 11(2):69-146. PubMed ID: 18188738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of six months of daily low-dose perchlorate exposure on thyroid function in healthy volunteers.
    Braverman LE; Pearce EN; He X; Pino S; Seeley M; Beck B; Magnani B; Blount BC; Firek A
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2721-4. PubMed ID: 16636123
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modulation of thyroid hormone concentrations in serum of rats coadministered with perchlorate and iodide-deficient diet.
    Kunisue T; Fisher JW; Kannan K
    Arch Environ Contam Toxicol; 2011 Jul; 61(1):151-8. PubMed ID: 21573761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bayesian population analysis of a harmonized physiologically based pharmacokinetic model of trichloroethylene and its metabolites.
    Hack CE; Chiu WA; Jay Zhao Q; Clewell HJ
    Regul Toxicol Pharmacol; 2006 Oct; 46(1):63-83. PubMed ID: 16889879
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of an integrated multi-species and multi-dose route PBPK model for volatile methyl siloxanes - D4 and D5.
    McMullin TS; Yang Y; Campbell J; Clewell HJ; Plotzke K; Andersen ME
    Regul Toxicol Pharmacol; 2016 Feb; 74 Suppl():S1-13. PubMed ID: 26724268
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relative potencies and additivity of perchlorate, thiocyanate, nitrate, and iodide on the inhibition of radioactive iodide uptake by the human sodium iodide symporter.
    Tonacchera M; Pinchera A; Dimida A; Ferrarini E; Agretti P; Vitti P; Santini F; Crump K; Gibbs J
    Thyroid; 2004 Dec; 14(12):1012-9. PubMed ID: 15650353
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An upper-bound assessment of the benefits of reducing perchlorate in drinking water.
    Lutter R
    Risk Anal; 2014 Oct; 34(10):1944-56. PubMed ID: 25196433
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a physiologically-based pharmacokinetic model of 2-phenoxyethanol and its metabolite phenoxyacetic acid in rats and humans to address toxicokinetic uncertainty in risk assessment.
    Troutman JA; Rick DL; Stuard SB; Fisher J; Bartels MJ
    Regul Toxicol Pharmacol; 2015 Nov; 73(2):530-43. PubMed ID: 26188115
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development and specification of physiologically based pharmacokinetic models for use in risk assessment.
    Clewell RA; Clewell HJ
    Regul Toxicol Pharmacol; 2008 Feb; 50(1):129-43. PubMed ID: 18077066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Iodine counteracts perchlorate effects in frogs.
    Renner R
    Environ Sci Technol; 2003 Feb; 37(3):52A. PubMed ID: 12630449
    [No Abstract]   [Full Text] [Related]  

  • 53. Development of a rat dosimetry model for bromate.
    Fisher J; Bull RJ
    Toxicology; 2006 Apr; 221(2-3):235-40. PubMed ID: 16500013
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parameters for pyrethroid insecticide QSAR and PBPK/PD models for human risk assessment.
    Knaak JB; Dary CC; Zhang X; Gerlach RW; Tornero-Velez R; Chang DT; Goldsmith R; Blancato JN
    Rev Environ Contam Toxicol; 2012; 219():1-114. PubMed ID: 22610175
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Physiologically-based toxicokinetic model for the prediction of perchlorate distribution and its application.
    Zhang L; Jiang J; Jia W; Wan X; Li Y; Jiao J; Zhang Y
    Environ Pollut; 2023 Feb; 318():120856. PubMed ID: 36513174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of short-term low-dose perchlorate on various aspects of thyroid function.
    Lawrence JE; Lamm SH; Pino S; Richman K; Braverman LE
    Thyroid; 2000 Aug; 10(8):659-63. PubMed ID: 11014310
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of in vitro biotransformation data and pharmacokinetic modeling to risk assessment.
    Kedderis GL; Lipscomb JC
    Toxicol Ind Health; 2001 Jun; 17(5-10):315-21. PubMed ID: 12539878
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A physiologically based pharmacokinetic model for atrazine and its main metabolites in the adult male C57BL/6 mouse.
    Lin Z; Fisher JW; Ross MK; Filipov NM
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):16-31. PubMed ID: 21094656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pediatric neurobehavioral diseases in Nevada counties with respect to perchlorate in drinking water: an ecological inquiry.
    Chang S; Crothers C; Lai S; Lamm S
    Birth Defects Res A Clin Mol Teratol; 2003 Oct; 67(10):886-92. PubMed ID: 14745943
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of novel inhalation kinetic studies to refine physiologically-based pharmacokinetic models for ethanol in non-pregnant and pregnant rats.
    Martin SA; Oshiro WM; Evansky PA; Degn LL; Ledbetter AD; Ford J; Todd Krantz Q; LeFew WR; Beasley TE; El-Masri H; McLanahan ED; Boyes WK; Bushnell PJ
    Inhal Toxicol; 2014 Aug; 26(10):598-619. PubMed ID: 25144475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.